Please assess the completion status of the following clinical trial:

Trial Title: Per-operating Use of a Probe for Detection of β+

Study Design Characteristics:
- Allocation: None
- Intervention Model: SINGLE_GROUP
- Observational Model: None
- Primary Purpose: DIAGNOSTIC
- Time Perspective: None
- Masking: NONE
- Phase: None
- Number of Arms: 1.0

Eligibility Criteria:
Inclusion Criteria:~* Age \< 80 years old;~* Karnofsky index ≥80% ;~* Informed consent signed~* Patients with an indication of thoracic, visceral, or ENT surgery with the aim of a diagnostic biopsy, of an invasive minimal treatment, or an initial or complementary resection~Exclusion Criteria:~* Pregnancy~* Enable to sign informed consent

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: 80 Years
- Healthy Volunteers: f

Study Arms:
- 18F-FDG PET/CT (Type: EXPERIMENTAL): 18F-FDG radiotracer All patients will undergo a 18F-FDG PET/CT and a surgery with probe detection of β+''

Based on this trial design, predict the completion outcome and termination type (if applicable).